United States· US:0480-1241_fbd28edb-7838-4c56-84e1-ad948cd2005c
Lenalidomide
A lenalidomide product containing lenalidomide, registered in United States by Teva Pharmaceuticals, Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Lenalidomide is registered in 16 of 19 countries.
Countries holding a registration under ATC L04AX04 (lenalidomide), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Lenalidomide · ATC L04AX04
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lenalidomide costs, country by country.
Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lenalidomide · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$47.45
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- LENALIDOMIDE
- Manufacturer
- Teva Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- L04AX04
- ATC class
- Lenalidomide
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc110480-1241-28
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
397 interactions on record for lenalidomide.
Graded by severity as the source publishes them — 75 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lenalidomide · interactions on record
397 records
- 75 severe
- 105 moderate
- 1 minor
- 216 info
Most severe, free to view
- ErythropoietinB03XA01severe
- Darbepoetin alfaB03XA02severe
- PeginesatideB03XA04severe
- C1-inhibitor, plasma derivedB06AC01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lenalidomide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IcelandFerulinorSTADA Nordic ApS.
- NetherlandsLenalidomide Accord 2,5 mg harde capsulesAccord Healthcare S.L.U.
- PolandLenalidomide AccordAccord Healthcare S.L.U.
- SpainLENALIDOMIDA ACCORD 2,5 MG CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- SwitzerlandLenalidomid Accord
- SwedenFerulinor 2,5 mg Kapsel, hårdSTADA Nordic ApS
- FinlandFerulinorSTADA Nordic ApS
- United KingdomLenalidomide 2.5mg capsulesGrindeks Kalceks UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Lenalidomid +pharma, Lenalidomid Biocon
- Belgium · Lenalidomid Grindeks, Lenalidomide Eg
- Bulgaria · Lenalidomide Sandoz, Леналидомид Алкалоид-Инт
- Cyprus · 7,5 Mg Stada, Lenalidomide Grindeks
- Czechia · Lenalidomid Sandoz, Lenalidomid Stada
- Germany · Lenabdor, Lenalidomid 123-Acurae Pharma
- Denmark · Lenalidomid Grindeks, Lenalidomid Medical Valley
- Estonia · Lenalidomide Auxilia, Lenalidomide Grindeks
- Spain · Lenalidomida Aurovitas, Lenalidomida Grindeks
- Finland · Ferulinor Stada, Lenalidomid Avansor
- France · Lenalidomide Arrow, Lenalidomide Eg
- United Kingdom (Northern Ireland) · Lenalidomide, Lenalidomide Amarox
- Greece · Cortedal, Lenalidomide
- Croatia · Lenalidomid Alkaloid-Int, Lenalidomid Grindeks
- Hungary · Lenalidomid Teva, Lenalidomide Grindeks
- Ireland · Lenalidomide Clonmel, Lenalidomide Grindeks
- Iceland · Cortedal, Ferulinor
- Italy · Kleder, Lenalidomide Aurobindo
- Liechtenstein · Lenalidomide Accord, Lenalidomide Mylan
- Lithuania · Lenalidomide G.L., Lenalidomide Grindeks
- Luxembourg · Lenalidomide, Lenalidomide Eg
- Latvia · Lenalidomide Grindeks, Lenalidomide Norameda
- Malta · Lenalidomida Generis, Lenalidomide Generis
- Netherlands · Lenalidomide Alkaloid-Int, Lenalidomide Amarox
- Norway · Ferulinor, Lenalidomid Medical Valley
- Poland · Kleder, Lenalidomide Eugia
- Portugal · Lenalidomida Biocon, Lenalidomida Generis
- Romania · Lenalidomidă Alkaloid-Int, Lenalidomidă Grindeks
- Sweden · Ferulinor, Lenalidomid Avansor
- Slovenia · Lenabdor, Lenalidomid Alkaloid-Int
- Slovakia · Lenalidomid Glenmark, Lenalidomid Grindeks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fff0a907-fbca-4e79-877b-61a45379d846 GET /v1/drugs/fff0a907-fbca-4e79-877b-61a45379d846?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2.5",
"substance": "LENALIDOMIDE",
"productndc": "0480-1241",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA201452",
"marketing_category": "ANDA"
}See everything about lenalidomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.